1552286-86-8

Basic information

• Product Name: C₂₁H₂₀ClN₅O₂
• Synonyms: C₂₁H₂₀ClN₅O₂
• CAS NO: 1552286-86-8
• Molecular Weight: 409.875
• Mol File: 1552286-86-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₂₁H₂₀ClN₅O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₁H₂₀ClN₅O₂(1552286-86-8)
• EPA Substance Registry System: C₂₁H₂₀ClN₅O₂(1552286-86-8)

Safety Data

• Hazardous Substances Data: 1552286-86-8(Hazardous Substances Data)

Upstream product

• 1260519-71-8 3-chloro-2-methyl-pyrido[2,3-b]pyrazine 
• 56961-30-9 2-chloro-5-hydroxybenzoic acid 
• 39062-63-0 2-chloro-5-hydroxybenzoic acid ethyl ester 
• 452-58-4 2,3-Diaminopyridine 
• 128102-80-7 2-methylpyrido<2,3-b>pyrazin-3(4H)-one 
• 1552286-23-3 C₂₁H₁₈ClN₅O₂ 
• 1552285-69-4 2-chloro-5-hydroxybenzoic acid ethyl ester 
• 1552286-43-7 C₁₅H₁₀ClN₅O 
• 1552286-22-2 C₂₃H₂₂ClN₅O₃ 

Relevant articles and documents

4-METHYL-2,3,5,9,9B-PENTAAZA-CYCLOPENTA[A]NAPHTHALENES

The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.